PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Ensysce Biosciences, Inc.
Filed: February 21, 2020
Period of Report: February 21, 2020
Accession Number: 0001213900-20-004506

View Document ↗ View on SEC.gov ↗